DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradia...
DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Esophageal cancer (ECa) is associated with high mortality, mostly due to late diagnosis, precluding curativeintent surgery. Hence, neoadjuvant chemoradiation (ChRT) is recommended in most patients regardless of histological subtype. A proportion of these patients, however, achieve complete disease remission and might be spared of radi...
Alternative Titles
Full title
DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_d970b954e26b4a219791784a6f9bb2cf
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d970b954e26b4a219791784a6f9bb2cf
Other Identifiers
ISSN
2045-7634
E-ISSN
2045-7634
DOI
10.1002/cam4.5623
